Statistics from Altmetric.com
Parodis I, Zickert A, Sundelin B, et al. Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy. Lupus Sci Med 2015;2:e000061. doi:10.1136/lupus-2014-000061.
In Table 1, the characteristic ‘Duration of induction therapy' should be named ‘Time between renal biopsies (months)'.
Page 4, right column, ‘the decrease in APRIL levels were significant…’ should read ‘the decrease in APRIL was significant…’.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.